Li G, Cappuccini F, Marchevsky NG, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial. Lancet 2022;399:2212-2225.
PMID: 35691324